Jacob Hallesy

Jacob Hallesy

Auto-generated profile, based on publicly available information

Jacob Hallesy

Department of Surgery, Virginia Commonwealth University School of Medicine

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in Clinical Transplantation
Verified
Journal Article
Open access
DIDaisuke Imai
Daisuke Imai
JHJacob Hallesy
Jacob Hallesy
RRRohan Rathi
Rohan Rathi
CZChristian Zbihley
Christian Zbihley
.S.Kush Savsani
.Kush Savsani
SLSeung Duk Lee
Seung Duk Lee
Normothermic regional perfusion (NRP) has emerged as a pivotal strategy in controlled donation after circulatory death (cDCD) liver transplantation, mitigating ischemia‐reperfusion injury and improving graft outcomes. Compared to super rapid recovery (SRR), NRP significantly reduces rates of early allograft dysfunction, primary nonfunction, and biliary non‐anastomotic stricture (NAS), with biliary complications reported in 5%–16% and NAS as low as 0%–2%. Outcomes from cDCD‐NRP grafts are increasingly comparable to those of donation after brain death (DBD). Viability assessment during NRP remains variably defined across centers. Nonetheless, stable pump flow, stable or declining lactate levels, controlled transaminase levels, and favorable macroscopic appearance are commonly used parameters. Histological thresholds may guide graft acceptance but are not universally applied. Sequential use of ex situ machine perfusion following NRP offers additional benefits in marginal or prolonged ischemia settings. NRP implementation has improved liver utilization rates from 34% to 63% in the United Kingdom and from 39% to 71% in the United States. This review highlights NRP as a transformative platform that reshapes viability standards, expanding transplant access, and supports sustained growth in liver transplantation.

5 June 2026 in Surgery
Verified
Journal Article
Closed access
JHJacob Hallesy
Jacob Hallesy
RRRohan Rathi
Rohan Rathi
DIDaisuke Imai
Daisuke Imai
YSYuzuru Sambommatsu
Yuzuru Sambommatsu
VKVinay Kumaran
Vinay Kumaran
SLSeung Duk Lee
Seung Duk Lee

14 April 2026 in Liver Transplantation
Verified
Journal Article
Closed access
SWSamuel Wolfe
Samuel Wolfe
SNShashank Nadimpalli
Shashank Nadimpalli
DIDaisuke Imai
Daisuke Imai
YSYuzuru Sambommatsu
Yuzuru Sambommatsu
MDMallika Datta
Mallika Datta
SLSeung Duk Lee
Seung Duk Lee

28 October 2026 in The American Surgeon™
Verified
Journal Article
Closed access
JHJacob Hallesy
Jacob Hallesy
APAndrew Min-Gi Park
Andrew Min-Gi Park
DIDaisuke Imai
Daisuke Imai
YSYuzuru Sambommatsu
Yuzuru Sambommatsu
VKVinay Kumaran
Vinay Kumaran
SLSeung Duk Lee
Seung Duk Lee
Background: Previous abdominal surgery (PAS) complicates open and laparoscopic living donor hepatectomy through intra-abdominal adhesions. Whether a robotic-intended strategy is feasible in donors with prior operations has not been described. A single-center experience in carefully selected donors is described. Methods: All living donor hepatectomies at a single US center (August 2019 to December 2024) were reviewed. The primary intention-to-treat cohort comprised all 31 robotic-intended cases (13 PAS, 18 No-PAS), and the 28 cases intended for fully robotic completion served as a sensitivity analysis. PAS was classified as upper or lower abdominal. Exploratory comparisons appear as effect estimates with 95% confidence intervals. Results: Robotic-intended hepatectomy was completed in all 13 PAS donors, 5 with prior upper abdominal surgery. Neither bile leak nor liver failure developed in a PAS donor, and adhesions accounted for no conversion. Blood loss, operative time, and hospital stay did not differ significantly, yet the confidence intervals stayed wide (hospital stay difference 1 day (95% CI −0.5 to 3)), so similarity cannot be established. Ileus affected 6 of 13 PAS donors and clustered in the upper abdominal subgroup, 4 of 5 (80.0%; 95% CI 28.4 to 99.5%); across all 12 events, 11 were Clavien-Dindo grade I. Discussion: At an experienced center, a robotic-intended strategy proved feasible across varied previous operations. The donors described here were selected, so safety or equivalence cannot be established. Lower abdominal PAS may be managed routinely, whereas upper abdominal PAS calls for selective use in experienced programs together with prospective study.

8 September 2026 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
JHJacob Hallesy
Jacob Hallesy
DNDerick Nguyen
Derick Nguyen
DVDevi Preetham Reddy Veeramgari
Devi Preetham Reddy Veeramgari
DIDaisuke Imai
Daisuke Imai
YSYuzuru Sambommatsu
Yuzuru Sambommatsu
SLSeung Duk Lee
Seung Duk Lee
Background: Robotic donor nephrectomy (RDN) offers a minimally invasive alternative to open and laparoscopic techniques for living kidney donation. As obesity rises among potential donors, data comparing RDN outcomes between non-obese and obese donors remain limited. This study evaluates the safety and feasibility of RDN in obese living kidney donors. Methods: A single-center retrospective analysis included 212 consecutive donors who underwent RDN between August 2020 and April 2025; after excluding one donor with incomplete covariate data, 211 (137 low BMI [< 30 kg/m 2 ], 74 high BMI [≥ 30 kg/m 2 ]) formed the analytic cohort. To account for baseline imbalance, the primary between-group comparison used propensity-score overlap weighting, with weighted differences and 95% confidence intervals (CIs) estimated by robust weighted regression. Results: Low BMI donors were modestly older (46.2 vs. 42.2 years; largest imbalance, standardized mean difference 0.32); overlap weighting reduced all covariate differences to approximately zero. After weighting, operating time was longer in high BMI donors (weighted difference + 15.6 min, 95% CI 6.4–24.8; p < 0.001), whereas estimated blood loss, conversion to open surgery (1.4% vs. 0.7%), complications (2.7% vs. 2.2%; all Clavien–Dindo Grade I), length of stay, and renal function through six months did not differ (all weighted p > 0.10). No perioperative deaths occurred. Exploratory subgroup analyses showed longer operating times for high BMI donors with single renal arteries ( p = 0.011) and left nephrectomies ( p = 0.024), without differences in blood loss or complications. Conclusion: In a rigorously selected cohort, RDN yielded short-term perioperative and functional outcomes in obese donors comparable to non-obese donors, with only a modest increase in operative time that persisted after overlap weighting. These findings support RDN as one component of responsibly expanding the donor pool; however, short-term parity does not establish long-term donor or recipient safety, and expansion must remain contingent on stringent selection, risk counseling, and structured long-term surveillance.